Walleye Capital LLC Imara Inc. Transaction History

Walleye Capital LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 16, 2022	SELL	$1.15 - $2.41 $88,757 - $186,003	-77,180 Closed	0 $0
Q4 2021 Mar 03, 2022	SELL	$2.25 - $4.05 $203,573 - $366,431	-90,477 Reduced 53.97%	77,180 $173,000
Q3 2021 Nov 15, 2021	BUY	$4.08 - $7.83 $684,040 - $1.31 Million	167,657 New	167,657 $684,000
Q2 2021 Aug 16, 2021	SELL	$6.78 - $9.04 $228,506 - $304,675	-33,703 Closed	0 $0
Q1 2021 May 17, 2021	BUY	$8.18 - $23.98 $275,690 - $808,197	33,703 New	33,703 $284,000

104K

170K

Ticker IMRA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 26,287,300
Market Cap $552M
Description
IMARA Inc., a clinical-stage biopharmaceutical company, develops and commercializes therapeutics for patients with rare genetic disorders of hemoglobin. Its lead product candidate is IMR-687, an oral and once-a-day therapeutic that is in Phase 2b clinical trials for the treatment of sickle cell disease and ß-thalassemia. The company also develop...

Get notified when there are updates to the investment portfolio of Walleye Capital LLC, based on Form 13F filings with the SEC.

Stay updated on Walleye Capital LLC with notifications on news.